Codexis has expanded its three-yeas strategic collaboration with Arch Pharmalabs. Codexis' Indian subsidiary will offer multiple pharmaceutical intermediates and APIs made with its biocatalytic processes, including intermediates used to manufacture generic atorvastatin (Lipitor), as well as the API itself.
Codexis
Tuesday 26 August 2008
Codexis expands Arch deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment